Home - ExecEdge

Six Months In, AZA Law Firm’s Dallas Office Tracks Toward Its Year-One Plan

Six Months In, AZA Law Firm’s Dallas Office Tracks Toward Its Year-One Plan

By Exec Edge Editorial Staff AZA Law Firm opened its Dallas office at the Trammell Crow Center on January 1, 2026. The launch ended 32...

Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM

Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM

The Cancer Therapy Strategy VERAXA Is Betting the Company On

The Cancer Therapy Strategy VERAXA Is Betting the Company On

VERAXA Biotech Stock in Focus as Lead Cancer Program Reaches Development Milestone

VERAXA Biotech Stock in Focus as Lead Cancer Program Reaches Development Milestone

Six Months In, AZA Law Firm’s Dallas Office Tracks Toward Its Year-One Plan

Six Months In, AZA Law Firm’s Dallas Office Tracks Toward Its Year-One Plan

Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM

Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM

The Cancer Therapy Strategy VERAXA Is Betting the Company On

The Cancer Therapy Strategy VERAXA Is Betting the Company On

VERAXA Biotech Stock in Focus as Lead Cancer Program Reaches Development Milestone

VERAXA Biotech Stock in Focus as Lead Cancer Program Reaches Development Milestone

SkylineDx’s Merlin CP-GEP Granted FDA Breakthrough Device Designation

SkylineDx’s Merlin CP-GEP Granted FDA Breakthrough Device Designation

Imviva Biotech Granted FDA IDE Authorization for Cancer Treatment Trial

Tackling the AI Security Crisis: Pax8’s Rob Belgrave and SentinelOne’s Steve Stone, Live from Pax8 Beyond 2026

Tackling the AI Security Crisis: Pax8’s Rob Belgrave and SentinelOne’s Steve Stone, Live from Pax8 Beyond 2026

Input your search keywords and press Enter.